1. Home/
  2. Compounds/
  3. alisertib:navitoclax (2:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2alisertib:navitoclax (2:1 mol/mol)
PharmacoGx alisertib:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to alisertib:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA AC138969.4 CTRPv2 pan-cancer AAC 0.19 6e-07
mRNA ACAA2 CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA ACAP3 CTRPv2 pan-cancer AAC 0.12 0.0004
mRNA ACAT1 CTRPv2 pan-cancer AAC -0.12 0.001
mRNA ACER2 CTRPv2 pan-cancer AAC 0.12 0.0005
mRNA ACRV1 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA ACSL3 CTRPv2 pan-cancer AAC -0.14 0.0003
mRNA ACTL6B CTRPv2 pan-cancer AAC 0.17 5e-06
mRNA ACVR1B CTRPv2 pan-cancer AAC 0.13 0.0006
mRNA ACVR2B CTRPv2 pan-cancer AAC 0.15 9e-05
Download CSV